Dr. Martens

Northampton, United Kingdom Founded: 1947 • Age: 79 yrs Listed Acquired By Permira
Footwear and clothing are designed and sold by Dr. Martens.

About Dr. Martens

Dr. Martens is a publicly listed company based in Northampton (United Kingdom) founded in 1947, and was acquired by Permira in October 2013. Footwear and clothing are designed and sold by Dr. Martens. The company has 2,350 employees. Its website drmartens.com draws about 11.6 million monthly visits. Dr. Martens offers products and services including DRM-Ico-File-SP01. Its focus areas include Consumer Goods, Apparel Brands, Casual Wear and Multi category. Its legal entity is DR. MARTENS PLC. Its competitors include Joules and Pepe Jeans London; 2 of its 2 listed competitors have raised funding.

Company details

Dr. Martens is a footwear and clothing brand. The brand was started by Klaus Märtena doctor in the German army during World War II, in 1947. He designed boots for injured feet, with soft leather and air-padded soles made of tires. In 1959, R. Griggs Group bought patent rights to manufacture the shoes in the UK. In October 2013 Permira, a PE firm acquired R. Griggs Group Limited (the owner of the Dr. Martens brand) for an amount of 300M.

  • Headquarters Northampton, United Kingdom
  • Employees 2,350
  • Stage Public
  • Sectors
    Retail
  • Website category Lifestyle · Fashion and Apparel
  • Website drmartens.com
  • Social LinkedIn X Facebook
  • Acquired by Permira (Oct 2013)
  • Legal Name Dr. Martens Plc
Key Metrics
  • Annual Revenue
    $1.01 B (USD)
    -2.72
    as on Mar 31, 2026
  • Net Profit
    $31.51 M (USD)
    428.89
    as on Mar 31, 2026
  • EBITDA
    $188.16 M (USD)
    6.6
    as on Mar 31, 2026
  • Investors
    Permira

    & 1 more

  • Employee Count
    2,350
  • Acquired by
    Permira

    (Oct 2013)

Products & Services of Dr. Martens

Dr. Martens offers a comprehensive portfolio of products and services, including DRM-Ico-File-SP01.

DRM-Ico-File-SP01
Footwear

Product code for Dr. Martens items available for global shipping

Funding Insights of Dr. Martens

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Dr. Martens with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2021Post-IPO––
Valuation history

2 investors in total: 2 institutional.

Investors in Dr. Martens

Dr. Martens has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Permira and BlackRock.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made in technology, consumer, healthcare, and service sectors.
1985permira.comLondon, United Kingdom
Diversified investment management firm and private fund focused on debt, equity, and secondary market investments in multiple sectors
1988blackrock.comNew York, United States
Premium access

Investor details for Dr. Martens

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Dr. Martens

116 people are tracked at Dr. Martens (45 in leadership, 5 in board & advisors, 66 in team); the tracked headcount is 2,350.

NameRoleGroup
Paul Mason
ChairmanLeadership
Robert Hanson
Non Executive DirectorLeadership
Benoit Vauchy
Non Executive DirectorLeadership
Louise Douglass
Head Of Finance (emea)Leadership
Rafael Matarazzo
Head Of Fp&a – Global Supply Chain, Technology And ProductLeadership
Junichi Takayose
Head Of WholesaleLeadership
Adam Meek
Chief Product OfficerLeadership
Christopher Tatlock
Global Head Of CRO & UXLeadership
Anna Wickes
Head Of RecommerceLeadership
John Francis
Global Head Of Energy (amp) MarketplaceLeadership
Anne-Sophie Barrellon
Head Of Real Estate, Construction And Facilities EMEALeadership
Braden Shields
Head Of Ecommerce, Asia PacificLeadership
Zoe Higgins
Head Of Studio ProductionLeadership
Geert Peeters
Chief Operating OfficerLeadership
Tony Au
VP Of Finance, APACLeadership
Mike I.
General Manager/representative Director (代表取締役社長) - JapanLeadership
Caleb Cheng
Head Of Brand Asia PacificLeadership
Acca Bhavini A Vanmali
Finance Business PartnerLeadership
Laura Marks
Global Head Of Fp&aLeadership
Richard Bee
Director Of Financial Control & Global Supply Chain FinanceLeadership

96 more people are available in the full profile.

Premium access

Complete people profiles for Dr. Martens

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Dr. Martens

Dr. Martens is a publicly listed company on the LSE with ticker symbol DOCS in UK, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date03 Feb 2021
  • Listed onLSE: DOCS
  • Listed entityDr. Martens Plc
  • Exchange sectorConsumer non-durables
  • ISINGB00BL6NGV24
  • Share price68.30 GBX (-0.87% on the day) · 2026-10-14
  • Market capitalisation659,490,128.00 GBX
  • Price to earnings28.1
  • EPS (diluted, trailing year)0.02 GBX
  • Dividend yield3.7%
  • Volume (last session)157,129

Financials of Dr. Martens

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025766.2M GBP23.8M GBP142.1M GBP
2024787.6M GBP4.5M GBP133.3M GBP
2023877.1M GBP69.2M GBP198.7M GBP
20221.00B GBP128.9M GBP245.0M GBP
2021908.3M GBP181.2M GBP269.4M GBP
Premium access

Detailed financial statements for Dr. Martens

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Dr. Martens

4 dated milestones of Dr. Martens across 74 years, from founding to its latest funding, stage changes and deals.

  1. Founded Dr. Martens is founded.
  2. Exit Acquired by Permira.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding First funding round.

Competitors of Dr. Martens

Dr. Martens has 2 listed competitors in our database, 2 of them funded. They include Joules and Pepe Jeans London.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
joules.com1989Market Harborough, United Kingdom$35.15M
Internet first brand of fashion apparel wear for men and women
pepejeans.com1973London, United Kingdom$177.5M172
Internet first brand of denim apparel wear for men and women
Premium access

Detailed competitors of Dr. Martens

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Dr. Martens

The website of Dr. Martens (drmartens.com) receives about 11.6M visits a month and ranks #3,808 among all websites worldwide, #153 in Fashion and Apparel.

  • Monthly visits
    11.6M

    ▼ 10.8% vs previous month

  • Unique visitors
    5.9M

    per month

  • Global rank
    #3,808

    among all websites

  • Category rank
    #153

    Lifestyle · Fashion and Apparel

Similar websites

Websites whose visitors overlap most with Dr. Martens. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
zappos.com
100%
20.7M#1,928View details
redwingshoes.com
96%
2.3M#21,025View details
timberland.com
90%
8.6M#4,474View details
uniqlo.com
88%
105.4M#219View details
journeys.com
88%
5.9M#4,764View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Dr. Martens

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Dr. Martens

Premium access

Complete news archive for Dr. Martens

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dr. Martens

Dr. Martens was founded in 1947 and raised its 1st funding round 74 years after it was founded.

Dr. Martens is headquartered in Northampton, United Kingdom. It is registered at Northampton, Northamptonshire, United Kingdom.

Dr. Martens has 2,350 employees.

Annual revenue of Dr. Martens is $1.01B as on Mar 31, 2026.

Dr. Martens is a footwear and clothing brand. The brand was started by Klaus Märtena doctor in the German army during World War II, in 1947. He designed boots for injured feet, with soft leather and air-padded soles made of tires. In 1959, R. Griggs Group bought patent rights to manufacture the shoes in the UK. In October 2013 Permira, a PE firm acquired R. Griggs Group Limited (the owner of the Dr. Martens brand) for an amount of 300M.

Dr. Martens's top competitors include Pepe Jeans London and Joules.

Dr. Martens offers DRM-Ico-File-SP01.

Yes, Dr. Martens is publicly traded on LSE under the ticker symbol DOCS.

Dr. Martens has 2 investors. Key investors include Permira, and BlackRock.

Dr. Martens operates through Dr. Martens Plc.

Yes. Dr. Martens was acquired by Permira in October 2013.

The website of Dr. Martens receives about 11.6 million visits a month and ranks #3,808 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available